Cargando…

SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome

Detalles Bibliográficos
Autores principales:	Di Giacomo, Anna M., Gambale, Elisabetta, Monterisi, Santa, Valente, Monica, Maio, Michele
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196405/ https://www.ncbi.nlm.nih.gov/pubmed/32388171 http://dx.doi.org/10.1016/j.ejca.2020.04.026

Ejemplares similares

An immunomodulatory signature of responsiveness to immune checkpoint blockade therapy
por: Shen, Hongru, et al.
Publicado: (2020)

In vivo and in situ programming of tumor immunity by combining oncolytics and PD-1 immune checkpoint blockade
por: Bartee, Eric, et al.
Publicado: (2017)

IL-1R blockade is not effective in patients with hematological malignancies and severe SARS-CoV-2 infection
por: Villegas, Carolina, et al.
Publicado: (2020)

Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy
por: Benfaremo, Devis, et al.
Publicado: (2021)

Immune Checkpoint Blockade for Aspergillosis and Mucormycosis Coinfection
por: Banck, Jan Christoph, et al.
Publicado: (2021)

Fatal SARS-CoV-2 coinfection in course of EBV-associated lymphoproliferative disease
por: Roncati, Luca, et al.
Publicado: (2020)

Hiding in the dark: pan-cancer characterization of expression and clinical relevance of CD40 to immune checkpoint blockade therapy
por: Yan, Chi, et al.
Publicado: (2021)

Immunotherapy of brain metastases: breaking a “dogma”
por: Di Giacomo, Anna Maria, et al.
Publicado: (2019)

Are symptoms associated with SARS-CoV-2 infections evolving over time?
por: Ricco, M., et al.
Publicado: (2022)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing maintenance hemodialysis
por: Delgado Ureña, Ana, et al.
Publicado: (2023)

SARS-CoV-2 pandemia in Lombardy: the impact on family Paediatricians
por: Missaglia, Rinaldo, et al.
Publicado: (2020)

Dual immune checkpoint blockade for non-small cell lung cancer patients with PD-L1 high expression: calling an end?
por: Peng, Ling, et al.
Publicado: (2021)

Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy
por: Parmiani, Giorgio, et al.
Publicado: (2015)

Low titers of SARS-CoV-2 neutralizing antibodies after first vaccination dose in cancer patients receiving checkpoint inhibitors
por: Terpos, Evangelos, et al.
Publicado: (2021)

Cutaneous exanthema revealing Multisystem-Inflammatory Syndrome in adults (MIS-A) in the course of SARS-CoV-2 infection
por: Pernea, P., et al.
Publicado: (2023)

SARS-CoV-2 vaccine uptake, perspectives, and adverse reactions following vaccination in patients with cancer undergoing treatment
por: Figueiredo, J.C., et al.
Publicado: (2022)

Eating reflex epilepsy of presumed autoimmune etiology after SARS-CoV-2 vaccination
por: Vogrig, Alberto, et al.
Publicado: (2023)

Masks Reduce Viral Inoculum of SARS-CoV2
por: Gandhi, Monica, et al.
Publicado: (2021)

Long-lasting immune response to a mild course of PCR-confirmed SARS-CoV-2 infection: A cohort study
por: Kral, Sabrina, et al.
Publicado: (2021)

Mild disease course of SARS-CoV-2 infections and mild side effects of vaccination in Pompe disease: a cohort description
por: Ismailova, G., et al.
Publicado: (2022)

Immune checkpoint blockade in malignant mesothelioma: A novel therapeutic strategy against a deadly disease?
por: Calabrò, Luana, et al.
Publicado: (2014)

Painless thyroiditis in SARS-CoV-2 infection()
por: Barahona San Millán, Rebeca, et al.
Publicado: (2021)

Nasopharyngeal swabs during SARS-CoV-2 pandemic: a role for the otolaryngologist
por: Tagliabue, Marta, et al.
Publicado: (2020)

Living with COVID-19: could SARS-CoV-2 infection present a ping-pong effect?
por: LAGHI, ALESSANDRO, et al.
Publicado: (2021)

Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment
por: Gambale, Elisabetta, et al.
Publicado: (2022)

Outcomes Among Patients With or Without Obesity and With Cancer Following Treatment With Immune Checkpoint Blockade
por: Yoo, Seong-Keun, et al.
Publicado: (2022)

Chronic kidney disease and SARS-CoV-2 outbreak: Lazio region organizational model
por: Dominijanni, Sara, et al.
Publicado: (2020)

Seroprevalence of anti-SARS-CoV2 Antibodies in Umbrian Persons Living with HIV
por: Papalini, Chiara, et al.
Publicado: (2020)

New-Generation Quantitative Immunoassays for SARS-CoV-2 Antibody Detection: Need for Harmonization
por: Villalta, Danilo, et al.
Publicado: (2022)

Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix
por: Di Giacomo, Anna M., et al.
Publicado: (2021)

Angiotensin-receptor blockade in acute stroke
por: Rajendran, Srijithesh P.
Publicado: (2011)

CGRP-monoclonal antibodies and SARS-CoV-2 vaccination
por: Schiano di Cola, Francesca, et al.
Publicado: (2022)

Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays
por: Moran, Angelica, et al.
Publicado: (2020)

Facepiece filtering respirators with exhalation valve should not be used in the community to limit SARS-CoV-2 diffusion
por: Ippolito, Mariachiara, et al.
Publicado: (2020)

Recurrence of immune thrombocytopenia at the time of SARS-CoV-2 infection
por: Merli, Michele, et al.
Publicado: (2020)

Improved gut microbiota features after the resolution of SARS‑CoV‑2 infection
por: De Maio, Flavio, et al.
Publicado: (2021)

Myasthenic crisis following SARS-CoV-2 infection and delayed virus clearance in a patient treated with rituximab: clinical course and 6-month follow-up
por: Wanschitz, Julia V., et al.
Publicado: (2020)

The dynamics of antibodies to SARS-CoV-2 in a case of SARS-CoV-2 infection
por: Xia, Yong, et al.
Publicado: (2020)

Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19: Clinical outcomes of SARS-CoV-2-infected cancer patients undergoing surgery
por: Zou, Caifeng, et al.
Publicado: (2021)

Ultrasound-guided regional blockade – Is it always safe?
por: Kumar, Kamal, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sa4948umd09voap5jbegrbhgh6